Retargeting the management of hypercholesterolemia–focus on evolocumab
A Colletti, G Derosa, AFG Cicero - Therapeutics and Clinical Risk …, 2016 - Taylor & Francis
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
[HTML][HTML] Retargeting the management of hypercholesterolemia–focus on evolocumab
A Colletti, G Derosa, AFG Cicero - Therapeutics and Clinical Risk …, 2016 - ncbi.nlm.nih.gov
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
Retargeting the management of hypercholesterolemia-focus on evolocumab.
A Colletti, G Derosa, AFG Cicero - THERAPEUTICS AND CLINICAL …, 2016 - cris.unibo.it
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
[PDF][PDF] Retargeting the management of hypercholesterolemia–focus on evolocumab
A Colletti - Therapeutics and Clinical Risk Management, 2016 - scienceopen.com
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
Retargeting the management of hypercholesterolemia–focus on evolocumab
A Colletti, G Derosa, AFG Cicero - Therapeutics and Clinical …, 2016 - search.proquest.com
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
[PDF][PDF] Retargeting the management of hypercholesterolemia–focus on evolocumab
A Colletti - Therapeutics and Clinical Risk Management, 2016 - pdfs.semanticscholar.org
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
[引用][C] Retargeting the management of hypercholesterolemia—Focus on evolocumab
A Colletti, G Derosa, AF Cicero - THERAPEUTICS AND CLINICAL …, 2016 - iris.unipv.it
Retargeting the management of hypercholesterolemia — Focus on evolocumab IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …
Retargeting the management of hypercholesterolemia-focus on evolocumab.
A Colletti, G Derosa, AF Cicero - Therapeutics and Clinical Risk …, 2016 - europepmc.org
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
Retargeting the management of hypercholesterolemia--focus on evolocumab
A Colletti, G Derosa, AFG Cicero - Therapeutics and Clinical Risk …, 2016 - go.gale.com
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …
Retargeting the management of hypercholesterolemia-focus on evolocumab
A Colletti, G Derosa, AF Cicero - … and clinical risk …, 2016 - pubmed.ncbi.nlm.nih.gov
Hypercholesterolemia is one of the main risk factors for atherosclerosis and cardiovascular
diseases. The treatment is based on the modification of the diet and lifestyle and if …
diseases. The treatment is based on the modification of the diet and lifestyle and if …